Search Reports
Categories
Categories

Global Endoparasiticide Market

Global Endoparasiticide Market Research Report 2025(Status and Outlook)

Report Code : PHA2714
Published Date : 17 July, 1905 | No of Pages: 141

  • Report Description
  • Table of Contents
  • Companies Mentioned
  • Related Reports


Report Overview
The endoparasiticide market comprises pharmaceutical and veterinary products designed to treat and prevent internal parasitic infections in animals, including livestock, companion animals, and aquaculture species. These infections, caused by helminths (worms) and protozoa, can lead to significant health deterioration, reduced productivity in livestock, and economic losses for farmers. Endoparasiticides are administered orally, topically, or via injection, with formulations ranging from tablets and pastes to pour-ons and feed additives. The market is driven by increasing livestock production, rising pet ownership, and growing awareness of parasitic zoonoses. Regulatory approvals, resistance concerns, and demand for sustainable, broad-spectrum solutions further shape industry dynamics. Key players focus on innovation to enhance efficacy, safety, and ease of administration while complying with stringent veterinary drug regulations.

The global Endoparasiticide market size was estimated at USD 348.88 million in 2024 and is projected to grow at a compound annual growth rate (CAGR) of 5.20% during the forecast period.

This report offers a comprehensive and in-depth analysis of the global Endoparasiticide market, covering all critical facets from a broad macroeconomic overview to detailed micro-level insights. It examines market size, competitive landscape, emerging development trends, niche segments, key drivers and challenges, as well as conducts SWOT and value chain analyses.

The insights provided enable readers to understand the competitive dynamics within the industry and formulate effective strategies to enhance profitability and market positioning. Additionally, the report presents a clear framework for evaluating the current status and future outlook of business organizations operating in this sector.

A significant focus of this report lies in the competitive landscape of the global Endoparasiticide market. It offers detailed profiles of major players, including their market shares, performance metrics, product portfolios, and operational status. This enables stakeholders to identify leading competitors and gain a nuanced understanding of market rivalry and structure.

In summary, this report serves as an essential resource for industry participants, investors, researchers, consultants, and business strategists, as well as anyone planning to enter or expand their presence in the Endoparasiticide market.
Global Endoparasiticide Market: Market Segmentation Analysis
This research report provides a detailed segmentation of the market by region (country), key manufacturers, product type, and application. Market segmentation divides the overall market into distinct subsets based on factors such as product categories, end-user industries, geographic locations, and other relevant criteria.
A clear understanding of these market segments enables decision-makers to tailor their product development, sales, and marketing strategies more effectively to meet the unique needs of each segment. Leveraging market segmentation insights can significantly enhance targeted approaches, optimize resource allocation, and accelerate product innovation cycles by aligning offerings with the specific demands of diverse customer groups.
Key Company
Boehringer Ingelheim
Elanco
Zoetis
Merck
Virbac
Novartis AG
Ceva Sante Animlae
Bayer AG
Eli Lilly
Vetoquinol

Market Segmentation (by Type)
Ear Tags
Tablets
Injectables
Feed Additives

Market Segmentation (by Application)
Veterinary Hospitals or Clinics
Animal Farms
Home Care Settings

Geographic Segmentation
North America (USA, Canada, Mexico)
Europe (Germany, UK, France, Russia, Italy, Rest of Europe)
Asia-Pacific (China, Japan, South Korea, India, Southeast Asia, Rest of Asia-Pacific)
South America (Brazil, Argentina, Columbia, Rest of South America)
The Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria, South Africa, Rest of MEA)

Key Benefits of This Market Research:
Industry drivers, restraints, and opportunities covered in the study
Neutral perspective on the market performance
Recent industry trends and developments
Competitive landscape & strategies of key players
Potential & niche segments and regions exhibiting promising growth covered
Historical, current, and projected market size, in terms of value
In-depth analysis of the Endoparasiticide Market
Overview of the regional outlook of the Endoparasiticide Market:

Customization of the Report
In case of any queries or customization requirements, please connect with our sales team, who will ensure that your requirements are met.
Chapter Outline
Chapter 1 mainly introduces the statistical scope of the report, market division standards, and market research methods.

Chapter 2 is an executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the Endoparasiticide Market and its likely evolution in the short to mid-term, and long term.

Chapter 3 makes a detailed analysis of the market\'s competitive landscape of the market and provides the market share, capacity, output, price, latest development plan, merger, and acquisition information of the main manufacturers in the market.

Chapter 4 is the analysis of the whole market industrial chain, including the upstream and downstream of the industry, as well as Porter\'s five forces analysis.

Chapter 5 introduces the latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 6 provides the analysis of various market segments according to product types, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 7 provides the analysis of various market segments according to application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 8 provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.

Chapter 9 shares the main producing countries of Endoparasiticide, their output value, profit level, regional supply, production capacity layout, etc. from the supply side.

Chapter 10 introduces the basic situation of the main companies in the market in detail, including product sales revenue, sales volume, price, gross profit margin, market share, product introduction, recent development, etc.

Chapter 11 provides a quantitative analysis of the market size and development potential of each region in the next five years.

Chapter 12 provides a quantitative analysis of the market size and development potential of each market segment in the next five years.

Chapter 13 is the main points and conclusions of the report.

Key Reasons to Buy this Report:
Access to date statistics compiled by our researchers. These provide you with historical and forecast data, which is analyzed to tell you why your market is set to change
This enables you to anticipate market changes to remain ahead of your competitors
You will be able to copy data from the Excel spreadsheet straight into your marketing plans, business presentations, or other strategic documents
The concise analysis, clear graph, and table format will enable you to pinpoint the information you require quickly
Provision of market value data for each segment and sub-segment
Indicates the region and segment that is expected to witness the fastest growth as well as to dominate the market
Analysis by geography highlighting the consumption of the product/service in the region as well as indicating the factors that are affecting the market within each region
Competitive landscape which incorporates the market ranking of the major players, along with new service/product launches, partnerships, business expansions, and acquisitions in the past five years of companies profiled
Extensive company profiles comprising of company overview, company insights, product benchmarking, and SWOT analysis for the major market players
The current as well as the future market outlook of the industry concerning recent developments which involve growth opportunities and drivers as well as challenges and restraints of both emerging as well as developed regions
Includes in-depth analysis of the market from various perspectives through Porter’s five forces analysis
Provides insight into the market through Value Chain
Market dynamics scenario, along with growth opportunities of the market in the years to come
6-month post-sales analyst support
Customization of the Report
In case of any queries or customization requirements, please connect with our sales team, who will ensure that your requirements are met.



  Table of Contents
  1 Research Methodology and Statistical Scope
      1.1 Market Definition and Statistical Scope of Endoparasiticide
      1.2 Key Market Segments
            1.2.1 Endoparasiticide Segment by Type
            1.2.2 Endoparasiticide Segment by Application
      1.3 Methodology & Sources of Information
            1.3.1 Research Methodology
            1.3.2 Research Process
            1.3.3 Market Breakdown and Data Triangulation
            1.3.4 Base Year
            1.3.5 Report Assumptions & Caveats
  2 Endoparasiticide Market Overview
      2.1 Global Market Overview
            2.1.1 Global Endoparasiticide Market Size (M USD) Estimates and Forecasts (2020-2033)
            2.1.2 Global Endoparasiticide Sales Estimates and Forecasts (2020-2033)
      2.2 Market Segment Executive Summary
      2.3 Global Market Size by Region
  3 Endoparasiticide Market Competitive Landscape
      3.1 Company Assessment Quadrant
      3.2 Global Endoparasiticide Product Life Cycle
      3.3 Global Endoparasiticide Sales by Manufacturers (2020-2025)
      3.4 Global Endoparasiticide Revenue Market Share by Manufacturers (2020-2025)
      3.5 Endoparasiticide Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
      3.6 Global Endoparasiticide Average Price by Manufacturers (2020-2025)
      3.7 Manufacturers’ Manufacturing Sites, Areas Served, and Product Types
      3.8 Endoparasiticide Market Competitive Situation and Trends
            3.8.1 Endoparasiticide Market Concentration Rate
            3.8.2 Global 5 and 10 Largest Endoparasiticide Players Market Share by Revenue
            3.8.3 Mergers & Acquisitions, Expansion
  4 Endoparasiticide Industry Chain Analysis
      4.1 Endoparasiticide Industry Chain Analysis
      4.2 Market Overview of Key Raw Materials
      4.3 Midstream Market Analysis
      4.4 Downstream Customer Analysis
  5 The Development and Dynamics of Endoparasiticide Market
      5.1 Key Development Trends
      5.2 Driving Factors
      5.3 Market Challenges
      5.4 Industry News
            5.4.1 New Product Developments
            5.4.2 Mergers & Acquisitions
            5.4.3 Expansions
            5.4.4 Collaboration/Supply Contracts
      5.5 PEST Analysis
            5.5.1 Industry Policies Analysis
            5.5.2 Economic Environment Analysis
            5.5.3 Social Environment Analysis
            5.5.4 Technological Environment Analysis
      5.6 Global Endoparasiticide Market Porter's Five Forces Analysis
            5.6.1 Global Trade Frictions
            5.6.2 U.S. Tariff Policy – April 2025
            5.6.3 Global Trade Frictions and Their Impacts to Endoparasiticide Market
      5.7 ESG Ratings of Leading Companies
  6 Endoparasiticide Market Segmentation by Type
      6.1 Evaluation Matrix of Segment Market Development Potential (Type)
      6.2 Global Endoparasiticide Sales Market Share by Type (2020-2025)
      6.3 Global Endoparasiticide Market Size Market Share by Type (2020-2025)
      6.4 Global Endoparasiticide Price by Type (2020-2025)
  7 Endoparasiticide Market Segmentation by Application
      7.1 Evaluation Matrix of Segment Market Development Potential (Application)
      7.2 Global Endoparasiticide Market Sales by Application (2020-2025)
      7.3 Global Endoparasiticide Market Size (M USD) by Application (2020-2025)
      7.4 Global Endoparasiticide Sales Growth Rate by Application (2020-2025)
  8 Endoparasiticide Market Sales by Region
      8.1 Global Endoparasiticide Sales by Region
            8.1.1 Global Endoparasiticide Sales by Region
            8.1.2 Global Endoparasiticide Sales Market Share by Region
      8.2 Global Endoparasiticide Market Size by Region
            8.2.1 Global Endoparasiticide Market Size by Region
            8.2.2 Global Endoparasiticide Market Size Market Share by Region
      8.3 North America
            8.3.1 North America Endoparasiticide Sales by Country
            8.3.2 North America Endoparasiticide Market Size by Country
            8.3.3 U.S. Market Overview
            8.3.4 Canada Market Overview
            8.3.5 Mexico Market Overview
      8.4 Europe
            8.4.1 Europe Endoparasiticide Sales by Country
            8.4.2 Europe Endoparasiticide Market Size by Country
            8.4.3 Germany Market Overview
            8.4.4 France Market Overview
            8.4.5 U.K. Market Overview
            8.4.6 Italy Market Overview
            8.4.7 Spain Market Overview
      8.5 Asia Pacific
            8.5.1 Asia Pacific Endoparasiticide Sales by Region
            8.5.2 Asia Pacific Endoparasiticide Market Size by Region
            8.5.3 China Market Overview
            8.5.4 Japan Market Overview
            8.5.5 South Korea Market Overview
            8.5.6 India Market Overview
            8.5.7 Southeast Asia Market Overview
      8.6 South America
            8.6.1 South America Endoparasiticide Sales by Country
            8.6.2 South America Endoparasiticide Market Size by Country
            8.6.3 Brazil Market Overview
            8.6.4 Argentina Market Overview
            8.6.5 Columbia Market Overview
      8.7 Middle East and Africa
            8.7.1 Middle East and Africa Endoparasiticide Sales by Region
            8.7.2 Middle East and Africa Endoparasiticide Market Size by Region
            8.7.3 Saudi Arabia Market Overview
            8.7.4 UAE Market Overview
            8.7.5 Egypt Market Overview
            8.7.6 Nigeria Market Overview
            8.7.7 South Africa Market Overview
  9 Endoparasiticide Market Production by Region
      9.1 Global Production of Endoparasiticide by Region(2020-2025)
      9.2 Global Endoparasiticide Revenue Market Share by Region (2020-2025)
      9.3 Global Endoparasiticide Production, Revenue, Price and Gross Margin (2020-2025)
      9.4 North America Endoparasiticide Production
            9.4.1 North America Endoparasiticide Production Growth Rate (2020-2025)
            9.4.2 North America Endoparasiticide Production, Revenue, Price and Gross Margin (2020-2025)
      9.5 Europe Endoparasiticide Production
            9.5.1 Europe Endoparasiticide Production Growth Rate (2020-2025)
            9.5.2 Europe Endoparasiticide Production, Revenue, Price and Gross Margin (2020-2025)
      9.6 Japan Endoparasiticide Production (2020-2025)
            9.6.1 Japan Endoparasiticide Production Growth Rate (2020-2025)
            9.6.2 Japan Endoparasiticide Production, Revenue, Price and Gross Margin (2020-2025)
      9.7 China Endoparasiticide Production (2020-2025)
            9.7.1 China Endoparasiticide Production Growth Rate (2020-2025)
            9.7.2 China Endoparasiticide Production, Revenue, Price and Gross Margin (2020-2025)
  10 Key Companies Profile
      10.1 Boehringer Ingelheim
            10.1.1 Boehringer Ingelheim Basic Information
            10.1.2 Boehringer Ingelheim Endoparasiticide Product Overview
            10.1.3 Boehringer Ingelheim Endoparasiticide Product Market Performance
            10.1.4 Boehringer Ingelheim Business Overview
            10.1.5 Boehringer Ingelheim SWOT Analysis
            10.1.6 Boehringer Ingelheim Recent Developments
      10.2 Elanco
            10.2.1 Elanco Basic Information
            10.2.2 Elanco Endoparasiticide Product Overview
            10.2.3 Elanco Endoparasiticide Product Market Performance
            10.2.4 Elanco Business Overview
            10.2.5 Elanco SWOT Analysis
            10.2.6 Elanco Recent Developments
      10.3 Zoetis
            10.3.1 Zoetis Basic Information
            10.3.2 Zoetis Endoparasiticide Product Overview
            10.3.3 Zoetis Endoparasiticide Product Market Performance
            10.3.4 Zoetis Business Overview
            10.3.5 Zoetis SWOT Analysis
            10.3.6 Zoetis Recent Developments
      10.4 Merck
            10.4.1 Merck Basic Information
            10.4.2 Merck Endoparasiticide Product Overview
            10.4.3 Merck Endoparasiticide Product Market Performance
            10.4.4 Merck Business Overview
            10.4.5 Merck Recent Developments
      10.5 Virbac
            10.5.1 Virbac Basic Information
            10.5.2 Virbac Endoparasiticide Product Overview
            10.5.3 Virbac Endoparasiticide Product Market Performance
            10.5.4 Virbac Business Overview
            10.5.5 Virbac Recent Developments
      10.6 Novartis AG
            10.6.1 Novartis AG Basic Information
            10.6.2 Novartis AG Endoparasiticide Product Overview
            10.6.3 Novartis AG Endoparasiticide Product Market Performance
            10.6.4 Novartis AG Business Overview
            10.6.5 Novartis AG Recent Developments
      10.7 Ceva Sante Animlae
            10.7.1 Ceva Sante Animlae Basic Information
            10.7.2 Ceva Sante Animlae Endoparasiticide Product Overview
            10.7.3 Ceva Sante Animlae Endoparasiticide Product Market Performance
            10.7.4 Ceva Sante Animlae Business Overview
            10.7.5 Ceva Sante Animlae Recent Developments
      10.8 Bayer AG
            10.8.1 Bayer AG Basic Information
            10.8.2 Bayer AG Endoparasiticide Product Overview
            10.8.3 Bayer AG Endoparasiticide Product Market Performance
            10.8.4 Bayer AG Business Overview
            10.8.5 Bayer AG Recent Developments
      10.9 Eli Lilly
            10.9.1 Eli Lilly Basic Information
            10.9.2 Eli Lilly Endoparasiticide Product Overview
            10.9.3 Eli Lilly Endoparasiticide Product Market Performance
            10.9.4 Eli Lilly Business Overview
            10.9.5 Eli Lilly Recent Developments
      10.10 Vetoquinol
            10.10.1 Vetoquinol Basic Information
            10.10.2 Vetoquinol Endoparasiticide Product Overview
            10.10.3 Vetoquinol Endoparasiticide Product Market Performance
            10.10.4 Vetoquinol Business Overview
            10.10.5 Vetoquinol Recent Developments
  11 Endoparasiticide Market Forecast by Region
      11.1 Global Endoparasiticide Market Size Forecast
      11.2 Global Endoparasiticide Market Forecast by Region
            11.2.1 North America Market Size Forecast by Country
            11.2.2 Europe Endoparasiticide Market Size Forecast by Country
            11.2.3 Asia Pacific Endoparasiticide Market Size Forecast by Region
            11.2.4 South America Endoparasiticide Market Size Forecast by Country
            11.2.5 Middle East and Africa Forecasted Sales of Endoparasiticide by Country
  12 Forecast Market by Type and by Application (2026-2033)
      12.1 Global Endoparasiticide Market Forecast by Type (2026-2033)
            12.1.1 Global Forecasted Sales of Endoparasiticide by Type (2026-2033)
            12.1.2 Global Endoparasiticide Market Size Forecast by Type (2026-2033)
            12.1.3 Global Forecasted Price of Endoparasiticide by Type (2026-2033)
      12.2 Global Endoparasiticide Market Forecast by Application (2026-2033)
            12.2.1 Global Endoparasiticide Sales (K MT) Forecast by Application
            12.2.2 Global Endoparasiticide Market Size (M USD) Forecast by Application (2026-2033)
  13 Conclusion and Key Findings
Boehringer Ingelheim
Elanco
Zoetis
Merck
Virbac
Novartis AG
Ceva Sante Animlae
Bayer AG
Eli Lilly
Vetoquinol
Please select License
Single User Price:$ 3200
Site License Price:$ 6400
Enterprise Price:$ 6400